Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactococcus lactis is a lactic acid bacterium primarily recognized for its role in the fermentation of dairy products, such as cheese and buttermilk. In recent years, interest has grown in its potential as a probiotic and an alternative or adjunct to antibiotics, particularly for supporting gut health and mitigating the impact of pathogenic bacteria. Scientific studies indicate that L. lactis can modulate the gut microbiota, produce antimicrobial peptides (such as nisin), and enhance the host immune response. Nisin, produced by certain strains of L. lactis, is a well-studied bacteriocin with the ability to inhibit a range of Gram-positive bacteria, including some antibiotic-resistant strains.

However, the evidence supporting the direct use of L. lactis as an alternative to conventional antibiotics in humans is limited. Most research has been conducted in vitro or in animal models, demonstrating reduced pathogen colonization and infection severity. Clinical studies in humans are sparse, and while L. lactis-based probiotics may help maintain a balanced microbiota during or after antibiotic use, robust data for its use as a standalone antibiotic alternative are lacking. Thus, while there is a scientific rationale and some promising preliminary data, the strength of evidence is moderate at best, supporting a rating of 2 out of 5. More rigorous clinical trials are needed to fully validate its effectiveness as an alternative to antibiotics.

More about Lactococcus lactis
More about Antibiotics (alternatives to)

Other ingredients used for Antibiotics (alternatives to)

Other health conditions supported by Lactococcus lactis

Products containing Lactococcus lactis